2m 2m 2m 2m 2m 2m 2m
CG ONCOLOGY (CGON)
NASDAQ
$72.31-$0.04 (-0.06%)
Price as of Sep 11, 2026 7:30 PM EDT- $6.4BMarket Cap
- 117.01%1-Year Change
- BiotechnologyIndustry
CG ONCOLOGY (CGON)
$72.31-$0.04 (-0.06%)
CGON | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $72.35 | ||
Change | +$0.35 (+0.49%) | ||
Open | $72.82 | ||
High | $75.00 | ||
Low | $71.53 | ||
Previous Close | $72.00 | ||
Volume | 759,835 | ||
30-Day Average Volume | 676,797 | ||
1-Week Change | -3.11% | ||
1-Month Change | -6.08% | ||
1-Year Change | 117.01% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 88.6M | ||
Total Assets | $1.1B | ||
Market Cap | $6.4B | ||
Enterprise Value | $6.4B | ||
Period: QTR TTM FY | |||
Revenue | $1.1M | ||
Net Income | -$79.1M | ||
Free Cash Flow | -$46.9M | ||
EBIT | -$79.1M | ||
EBITDA | -$78.2M | ||
Net Working Capital | $1.0B | ||
EPS | -$0.90 | ||
Enterprise Value/EBITDA | -82 | ||
Enterprise Value/Revenue | 5,577 | ||
P/B | 6 | ||
P/E | -80 | ||
PEG | 3 | ||
Price/Free Cash Flow | -137 | ||
Price/Operating Cash Flow | -138 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue